Structural insights and clinical advances in small-molecule inhibitors targeting TGF-β receptor I
The dysregulation of the transforming growth factor β (TGF-β) signaling pathway plays a critical role in the onset and progression of several diseases, including cancer. Notably, TGF-β has emerged as a significant barrier to effective outcomes in cancer immunotherapies, particularly those using immu...
Furkejuvvon:
| Váldodahkkit: | , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Elsevier
2025-03-01
|
| Ráidu: | Molecular Therapy: Oncology |
| Fáttát: | |
| Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S2950329925000141 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|